Fatty Acid-Modified Gapmer Antisense Oligonucleotide and sorted by
relevance

Admin25.08.2021

Fatty Acid-Modified Gapmer Antisense Oligonucleotide and

7100
Admin07.09.2021

(PDF) Fatty Acid-Modified Gapmer Antisense Oligonucleotide

Admin14.09.2021

Fatty Acid-Modified Gapmer Antisense Oligonucleotide and

4106
Admin11.09.2021

(PDF) Fatty Acid-Modified Gapmer Antisense Oligonucleotide

7306
Admin29.09.2021

(PDF) Fatty Acid-Modified Gapmer Antisense Oligonucleotide

7201
Admin22.09.2021

(PDF) Fatty Acid-Modified Gapmer Antisense Oligonucleotide

5104
Admin07.08.2021

BNA Gapmer Antisense RNA Oligonucleotides

701
Admin04.10.2021

Fatty Acid-Modified Gapmer Antisense Oligonucleotide and

7503
Admin14.08.2021

Fatty Acid-Modified Gapmer Antisense Oligonucleotide and

707
Admin14.09.2021

Antisense oligos

2906
Admin23.07.2021

The main chemically modified antisense oligonucleotides

5306
Admin03.09.2021

Design of chemically modified antimiR oligonucleotides. (A

73010
Admin23.08.2021

Antisense mechanisms. Antisense oligonucleotides (ASOs

2703
Admin26.07.2021

Evaluation of LNA and α-L-LNA antisense oligonucleotides

6104
Admin19.08.2021

Antisense oligonucleotides: modifications and clinical

4102
Admin18.08.2021

Antisense oligonucleotides (ASOs) reduce RNA foci in

71010
Admin21.07.2021

(PDF) Ribonuclease H1-dependent hepatotoxicity caused by

1301
Admin24.09.2021

(PDF) Ribonuclease H1-dependent hepatotoxicity caused by

707
Admin29.09.2021

Antisense oligonucleotide probe design. ( a ) Modified DNA

9709
Admin18.09.2021

( a ) Gap design of current generation of ASO therapeutics

3002
Admin08.10.2021

Design of several types of Toc-ASOs. | Download Scientific

1406